fbpx Skip to main content

Vendor News Article

Catch up on the latest deals and news

The Charles River World Congress on Animal Models in Drug Discovery and Development

  • 2017-07-07
  • Author: Heather Ramsay

Charles River has partnered with the EBD Group to provide the scientific program for this year’s BioPharm America™ conference. This conference is one of many that are held throughout the world that brings together researchers and funding groups for one common goal…fuel the pipeline and propel the future of drug development. This year, the conference will run during Boston Biotech Week (September 25-28, 2017) and while it is a week-long event, the scientific program component is only two days (September 26-27, 2017).

This is Charles Rivers' first conference of its type and one that will springboard future larger congresses. The agenda is packed with in-depth sessions in fields of research that include traditional and non-traditional animal models, novel in vitro and ex vivo approaches to disease modeling, the application of technologies such as CRISPR/Cas9 gene editing, 3D bioprinting, the exploitation of the microbiome, and co-opting the immune system in the treatment of disease. The program is very scientific and is definitely geared towards researchers.

Click here to find general information and to view the all-star lineup of speakers, agenda and registration information. Charles River even developed a trailer that will empower clients. One item that is different is that there will be two types of registration. As it is a global event, clients will have the option to register with an “All Access Pass” or via a “Virtual Pass” that allows them to attend in a real-time virtual environment, from anywhere in the world.

Take a look at the site for more information: http://breakthroughs.criver.com.